Valproate Administration to Mice Increases Histone Acetylation and 5-Lipoxygenase Content in the Hippocampus.

E Yildirim,ZJ Zhang,T Uz,CQ Chen,R Manev,H Manev

DOI: https://doi.org/10.1016/s0304-3940(03)00490-7

IF: 3.197

2003-01-01

Neuroscience Letters

Abstract:Gene expression can be regulated by chromatin remodeling induced by the opposing actions of histone acetyltransferases and histone deacetylases (HDAC). HDAC inhibitors are considered putative anti-cancer drugs, but may also alter gene expression in the brain. Valproic acid (valproate; VPA), a drug used for treatment of bipolar disorder, has been characterized as a HDAC inhibitor. In neuronal cultures, VPA increases the expression of 5-lipoxygenase (5-LOX). Here we show that in vivo treatment of mice with intraperitoneal VPA injections increases the acetylation of histone H3 and the content of 5-LOX immunoreactive protein in the hippocampus. Since the extent of 5-LOX expression may alter mouse behavior, we suggest that VPA-altered chromatin remodeling and 5-LOX expression in the brain may be functionally important.